C-type lectin Mincle initiates IL-17-mediated inflammation in acute exacerbations of idiopathic pulmonary fibrosis

C-type lectin Mincle initiates IL-17-mediated inflammation in acute exacerbations of idiopathic pulmonary fibrosis

Rationale: Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) has a poor prognosis and high mortality. However, there is limited information regarding the mechanisms of AE-IPF. Aims: We aimed to explore the function of macrophage-inducible C-type lectin (Mincle) in AE-IPF. Methods: In the...

Full description

Bibliographic Details
Main Authors:	Chen Tao, He Xian, Zhou Nian-yu, Song Jia-cui, Weng Dong, Li Hui-ping
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Biomedicine & Pharmacotherapy
Subjects:	Acute exacerbations of idiopathic pulmonary fibrosis Acute lung injury Mincle Th17
Online Access:	http://www.sciencedirect.com/science/article/pii/S0753332223000410

Similar Items

Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis
by: Keisuke Anan, et al.
Published: (2022-10-01)

Isoliquiritigenin Attenuates UUO-Induced Renal Inflammation and Fibrosis by Inhibiting Mincle/Syk/NF-Kappa B Signaling Pathway
by: Liao Y, et al.
Published: (2020-04-01)

Neutrophil-to-Lymphocyte Ratio in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Toru Arai, et al.
Published: (2023-11-01)

Acute exacerbation of idiopathic pulmonary fibrosis induced by pertussis: the first case report
by: Kuniaki Hirai, et al.
Published: (2019-01-01)

Successful Rescue of Acute Exacerbation of Idiopathic Pulmonary Fibrosis after Surgery for Lung Cancer: Case Report
by: Chuan HUANG, et al.
Published: (2022-05-01)

Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP)
by: Jean-Marc Naccache, et al.
Published: (2019-04-01)

Coronavirus disease 2019 vaccination‐induced acute exacerbation in idiopathic pulmonary fibrosis
by: Keishi Sugino, et al.
Published: (2022-11-01)

End-of-life care for idiopathic pulmonary fibrosis patients with acute exacerbation
by: Norimichi Akiyama, et al.
Published: (2022-10-01)

Clinical characteristics, comorbidities, and outcomes in patients with idiopathic pulmonary fibrosis
by: Esam H Alhamad, et al.
Published: (2020-01-01)

Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Yoshimasa Hachisu, et al.
Published: (2019-05-01)

Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosis
by: Ioannis Tomos, et al.
Published: (2021-08-01)

Diverse echocardiographic changes in the course of hypoxia due to acute exacerbation of idiopathic pulmonary fibrosis
by: Toshimitsu Tsugu, et al.
Published: (2020-09-01)

The balance between lung regulatory T cells and Th17 cells is a risk indicator for the acute exacerbation of interstitial lung disease after surgery: a case-control study
by: Mariko Fukui, et al.
Published: (2023-02-01)

Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis
by: Tejaswini Kulkarni, et al.
Published: (2024-03-01)

Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible
by: Elisabetta Balestro, et al.
Published: (2019-10-01)

Acute exacerbation of idiopathic pulmonary fibrosis model in the rats using bleomycin and lipopolysaccharides
by: Sandy Vitria Kurniawan, et al.
Published: (2023-06-01)

Proteomic characterization of idiopathic pulmonary fibrosis patients: stable versus acute exacerbation
by: Alfonso Carleo, et al.
Published: (2020-04-01)

Acute exacerbation of postoperative idiopathic pulmonary fibrosis in a patient with lung cancer caused by invasive mechanical ventilation: A case report
by: Bin Qiu, et al.
Published: (2023-11-01)

The NLRP3-Inflammasome-Caspase-1 Pathway Is Upregulated in Idiopathic Pulmonary Fibrosis and Acute Exacerbations and Is Inducible by Apoptotic A549 Cells
by: Benedikt Jäger, et al.
Published: (2021-04-01)

Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis
by: Miia Kärkkäinen, et al.
Published: (2018-05-01)

Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study
by: Kodai Kawamura, et al.
Published: (2017-06-01)

Species-Specific Structural Requirements of Alpha-Branched Trehalose Diester Mincle Agonists
by: Alyson J. Smith, et al.
Published: (2019-02-01)

Elevated Expression of Growth Differentiation Factor-15 Is Associated With Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Mengshu Cao, et al.
Published: (2022-06-01)

Prognostic differences among patients with idiopathic interstitial pneumonias with acute exacerbation of varying pathogenesis: a retrospective study
by: Motoyasu Kato, et al.
Published: (2019-12-01)

Exacerbation of idiopathic pulmonary fibrosis
by: S. N. Avdeev, et al.
Published: (2020-03-01)

Approach to acute exacerbation of idiopathic pulmonary fibrosis
by: Hammad Bhatti, et al.
Published: (2013-01-01)

The C-Type Lectin Mincle: Clues for a Role in Crohn’s Disease Adjuvant Reaction
by: Anje A. te Velde
Published: (2017-10-01)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Tomoo Kishaba
Published: (2019-03-01)

Acute exacerbation of idiopathic pulmonary fibrosis disease: a diagnosis model in China
by: Liye Meng, et al.
Published: (2024-03-01)

Acute exacerbation of idiopathic pulmonary fibrosis after inhalation of a water repellent
by: David Bennett, et al.
Published: (2015-08-01)

Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
by: Paola Faverio, et al.
Published: (2021-09-01)

Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now?
by: Ioannis Tomos, et al.
Published: (2023-10-01)

Prognosis of patients with acute exacerbation of combined pulmonary fibrosis and emphysema: a retrospective single-centre study
by: Yuichi Ikuyama, et al.
Published: (2020-05-01)

MCL and mincle: C-type lectin receptors that sense damaged self and pathogen associated molecular patterns
by: Mark B Richardson, et al.
Published: (2014-06-01)

Characterisation of the bovine C-type lectin receptor Mincle and potential evidence for an endogenous ligand
by: Angela Holder, et al.
Published: (2023-05-01)

Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation
by: Sung Woo Moon, et al.
Published: (2019-10-01)

Animal models of acute exacerbation of pulmonary fibrosis
by: Xu Ye, et al.
Published: (2023-11-01)

NHLRC2 expression is increased in idiopathic pulmonary fibrosis
by: Mervi Kreus, et al.
Published: (2022-08-01)

The efficacy of recombinant human soluble thrombomodulin (rhsTM) treatment for acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
by: Hiroyuki Kamiya, et al.
Published: (2020-03-01)

Exposure to PM2.5 is a risk factor for acute exacerbation of surgically diagnosed idiopathic pulmonary fibrosis: a case–control study
by: Masahiro Tahara, et al.
Published: (2021-03-01)